Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review
Nikolaos Kougkas, Athanasia Dara, Eleni Pagkopoulou, et al.
Rheumatology International (2022) Vol. 42, Iss. 10, pp. 1849-1854
Open Access | Times Cited: 12

Showing 12 citing articles:

Nanoarchitectonics of CTAB-modified kanemite as carrier of methotrexate
Yufeng Chen, Yijun Liu, Xiaoqiang Shang, et al.
Applied Clay Science (2024) Vol. 250, pp. 107279-107279
Closed Access | Times Cited: 5
Rheumatoid arthritis unmasked: the power of B cell depletion therapy
Tawfeeq Alghazali, Raed Obaid Saleh, Subasini Uthirapathy, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Norwogonin Attenuates Inflammatory Osteolysis and Collagen‐Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations
Haojue Wang, Tao Yuan, Yu Xiao, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 6
Open Access
Melittin: A Promising Therapeutic Agent for Rheumatoid Arthritis Treatment
Rong Huang, Xiying He, Qingxin Meng, et al.
Toxicon (2025), pp. 108335-108335
Closed Access
Rituximab, Apremilast, and Upadacitinib as Selected Biosimilar and Targeted Synthetic Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action: Their Current Use in Slowing Down the Progression of Disease
Piotr Kawczak, Igor Feszak, Tomasz Bączek
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2605-2605
Open Access
Melittin acupoint injection in attenuating bone erosion in collagen-induced arthritis mice via inhibition of the RANKL/NF-κB signaling pathway
Fenfang Liu, Fen Chen, Le Yang, et al.
Quantitative Imaging in Medicine and Surgery (2023) Vol. 13, Iss. 9, pp. 5996-6013
Open Access | Times Cited: 6
Impacts of methotrexate on survival, dendrite development, and synapse formation of cortical neurons
Mai Yamamura, Kenji Hanamura, Noriko Koganezawa, et al.
Genes to Cells (2023) Vol. 28, Iss. 8, pp. 563-572
Closed Access | Times Cited: 4
Methotrexate-induced leukoencephalopathy presenting as acute-onset limb weakness in a child: a case report
Hashan Pathiraja, Gayathri de Abrew, Linushika de Silva, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Drug Delivery System Based on CTAB/CS‐Modified Kanemite for Methotrexate and Its Cytotoxicity Against HepG2 Cells
Yijun Liu, Fang Guo, Xiaoqiang Shang, et al.
ChemistrySelect (2024) Vol. 9, Iss. 38
Open Access | Times Cited: 1
Fluorescent drug delivery system used for methotrexate and its inhibition against HepG2 cells
Xiaoqiang Shang, Tingting Li, Yijun Liu, et al.
Journal of the Iranian Chemical Society (2023) Vol. 21, Iss. 1, pp. 117-127
Closed Access | Times Cited: 3
Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system
Takeshi Honma, Kenji Onda, Koichi Masuyama
Frontiers in Drug Safety and Regulation (2024) Vol. 4
Open Access
Methotrexate/rituximab

Reactions Weekly (2022) Vol. 1919, Iss. 1, pp. 369-369
Closed Access
Page 1

Scroll to top